Nevro Corp.
(NYSE: NVRO)
Rigrodsky Law, P.A. is investigating Nevro Corp. (“Nevro”) regarding possible breaches of fiduciary duties and other violations of law related to Nevro’s agreement to be acquired by Globus Medical. Under the terms of the agreement, Nevro shareholders will receive $5.85 per share in cash.